Validation of EGSYS Score in Prediction of Cardiogenic Syncope
Table 2
Frequency of EGSYS risk factors in the studied patients.
Risk factors
Number (%)
OR3 (95% CI4)
value
Score#
EGSYS-U1
Abnormal ECG/cardiopathy
134 (67.3)
11.27 (5.42–23.01)
<0.001
Palpitations/dyspnea
59 (30.1)
7.48 (3.3–16.96)
<0.001
Syncope in supine position/effort syncope
68 (34.2)
1.37 (0.74–2.40)
0.315
Age >64 years
87 (45.1)
4.54 (2.24–8.53)
<0.001
No precipitating and predisposing factors
128 (65.6)
0.84 (0.46–1.53)
0.576
No prodromes
46 (23.6)
3.84 (1.73–8.52)
0.001
Blurred vision
40 (20.7)
5.12 (2.37–11.06)
<0.001
Neurovegetative signs during recovery phase
68 (35.2)
2.19 (1.20–4.01)
0.010
Precipitating and predisposing factors
67 (34.4)
0.84 (0.46–1.53)
0.575
Autonomic prodromes
67 (34.2)
0.13 (0.02–1.05)
0.055
EGSYS–M2
Abnormal ECG/cardiopathy
134 (67.3)
11.27 (5.42–23.01)
<0.001
Palpitations/dyspnea
59 (30.1)
7.48 (3.3–16.96)
<0.001
Effort syncope
51 (26.4)
0.94 (0.49–1.79)
0.844
Syncope in supine position
9 (9.8)
4.28 (1.20–15.25)
0.016
Autonomic prodromes
67 (34.2)
0.13 (0.02–1.05)
0.025
Precipitating and predisposing factors
67 (34.4)
0.84 (0.46–1.53)
0.575
Presence of one or more ECG abnormality listed in Definitions. Defined in Methods. Defined in Methods. #Total score ≥3 indicates patients at risk for presence of cardiac cause. 1EGSYS-U: Evaluation of Guidelines in Syncope Study-Univariate. 2EGSYS-M: Evaluation of Guidelines in Syncope Study-Multivariate. 3OR: odds ratio. 4CI: confidence interval.
